Kiniksa Pharmaceuticals International (KNSA) Change in Acquisitions & Divestments (2018 - 2026)

Kiniksa Pharmaceuticals International has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $145.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 230.83% year-over-year to $145.7 million; the trailing twelve-month figure through Mar 2026 stood at $301.1 million (up 35.59% YoY), and the FY2025 full-year result was $199.5 million, down 16.86% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $145.7 million, up from $40.8 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $145.7 million in Q1 2026, with the low at $7.5 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $52.3 million across 5 years, with a median of $44.0 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments slumped 94.61% — and 2024, when it surged 312.56%.
• Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments stood at $20.1 million in 2022, then soared by 128.75% to $46.0 million in 2023, then surged by 90.26% to $87.5 million in 2024, then slumped by 53.38% to $40.8 million in 2025, then surged by 257.17% to $145.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $145.7 million (Q1 2026), $40.8 million (Q4 2025), and $84.1 million (Q3 2025), per Business Quant data.